Janssen’s virtual reality support program for nurses wins Most Valuable HCP Initiative award
Helming an organization is a tall order, so what attributes separate the wheat from the chaff?
The pharma industry is on the cusp of a new dawn, but what does it look like?
“If the medicines are good, they’ll generate value”. It’s time to let the scientists lead the way, says AstraZeneca’s Mark Mallon